Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules is a research paper published in Genes (2021). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA215990
American Cancer Society
Grant: RSG-17-038-01
The Gray Foundation
Grant: -
NCI NIH HHS
Grant: R01 CA215990
National Institutes of Health
Grant: 5R01CA215990-05
Elucidating Cancer Risk in BRCA2 and RAD51 Variants
FWCI
2.42
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals